clinical trial · NCT03570957
A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients
Seasonal Allergic RhinitisMT-2990Placebo
brief summary
The objective of this study is to investigate the safety, tolerability, and pharmacokinetics of MT-2990 in patients with Japanese cedar pollen-induced seasonal allergic rhinitis (JC-SAR). Additional objective of the study is to investigate the efficacy and pharmacodynamics profile of MT-2990 in an environmental exposure chamber (EEC) on Day 8, 29, 57, and 85.
started
Jul 17, 2018
primary completion
Dec 27, 2018
completion
Dec 27, 2018
last updated
Dec 11, 2025
official title
A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients (Single Dose Study)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol